HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) (the “Company”) announced today the pricing of a public offering of 4,000,000 shares of its common stock at $28.50 per share. The shares are being offered by Deutsche Bank Securities Inc. as underwriter.
